0001232524-17-000183.txt : 20171121
0001232524-17-000183.hdr.sgml : 20171121
20171121172922
ACCESSION NUMBER: 0001232524-17-000183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171117
FILED AS OF DATE: 20171121
DATE AS OF CHANGE: 20171121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGill Iain
CENTRAL INDEX KEY: 0001615764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 171217828
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD
CITY: DUBLIN L2 4
STATE: L2
ZIP: 0
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-11-17
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001615764
McGill Iain
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4
L2
IRELAND
0
1
0
0
SVP, Europe & Rest of World
Ordinary Shares
2017-11-17
4
M
0
8000
46.83
A
28383
D
Ordinary Shares
2017-11-17
4
S
0
8000
133.4197
D
20383
D
Non-Qualified Stock Option (right to buy)
46.83
2017-11-17
4
M
0
8000
133.4197
D
2022-08-08
Ordinary Shares
8000
4500
D
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $132.95 to $133.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
This non-qualified stock option was granted on August 9, 2012 and vested over a period four years from date of grant. The options were fully vested as of August 9, 2016.
By: /s/Doris Choi as attorney in fact For: Iain McGill
2017-11-21